Zura Bio (ZURA) Other Non-Current Liabilities (2021 - 2024)
Zura Bio (ZURA) posted quarterly Other Non-Current Liabilities of $2.4 million for Q2 2024, up 14.26% year-over-year from $2.1 million in Q3 2023, and up 48.12% quarter-over-quarter from $1.6 million in Q1 2024.
Zura Bio (ZURA) Other Non-Current Liabilities (2021 - 2024) Analysis & Trends
Zura Bio's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $2.4 million for Q2 2024.
- In Q2 2024, Other Non-Current Liabilities rose 14.26% year-over-year to $2.4 million; the TTM figure through Jun 2024 stood at $2.4 million (up 14.26% YoY), while the FY2023 annual figure was $990000.0, down 90.47% from the prior year.
- Other Non-Current Liabilities for Q2 2024 stood at $2.4 million, up from $1.6 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $10.4 million in Q4 2022, with the low at $990000.0 in Q4 2023.
- The 4-year median for Other Non-Current Liabilities is $2.2 million (2023), against an average of $3.5 million.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities soared 71.17% in 2022, then plunged 90.47% in 2023.
- Zura Bio's Other Non-Current Liabilities stood at $6.1 million in 2021, then jumped by 71.17% to $10.4 million in 2022, then slumped by 90.47% to $990000.0 in 2023, then jumped by 138.79% to $2.4 million in 2024.
- Business Quant data shows ZURA's Other Non-Current Liabilities at $2.4 million in Q2 2024, $1.6 million in Q1 2024, and $990000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zura Bio | 706.30 Mn | 706.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 2.36 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 990,000.00 |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 2.07 Mn |
| Dec 31, 2022 | 10.39 Mn |
| Sep 30, 2022 | 2.05 Mn |
| Jun 30, 2022 | 2.36 Mn |
| Mar 31, 2022 | 5.53 Mn |
| Dec 31, 2021 | 6.07 Mn |